Safety and Pharmacokinetic Study of Fidaxomicin in Children With Clostridium difficile-Associated Diarrhea: A Phase 2a Multicenter Clinical Trial.

about

Safety and Pharmacokinetic Study of Fidaxomicin in Children With Clostridium difficile-Associated Diarrhea: A Phase 2a Multicenter Clinical Trial.

Item

http://www.wikidata.org/entity/Q38376098

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Safety and Pharmacokinetic Stu ...... 2a Multicenter Clinical Trial.

@en

type

Item

label

Safety and Pharmacokinetic Stu ...... 2a Multicenter Clinical Trial.

@en

prefLabel

Safety and Pharmacokinetic Stu ...... 2a Multicenter Clinical Trial.

@en

P1476

Safety and Pharmacokinetic Stu ...... 2a Multicenter Clinical Trial.

@en

P2093

Anthony Otley

http://www.w3.org/2001/XMLSchema#string

Edward J Hoffenberg

http://www.w3.org/2001/XMLSchema#string

Janice E Sullivan

http://www.w3.org/2001/XMLSchema#string

Kwang Sik Kim

http://www.w3.org/2001/XMLSchema#string

Larry K Kociolek

http://www.w3.org/2001/XMLSchema#string

Marian G Michaels

http://www.w3.org/2001/XMLSchema#string

Molly A O'Gorman

http://www.w3.org/2001/XMLSchema#string

Pamela Sears

http://www.w3.org/2001/XMLSchema#string

Sharon Nachman

http://www.w3.org/2001/XMLSchema#string

Sheldon L Kaplan

http://www.w3.org/2001/XMLSchema#string

P2860

Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management.

Viral co-infections are common and are associated with higher bacterial burden in children with clostridium difficile infection

Fidaxomicin versus vancomycin for Clostridium difficile infection.

Burden of Clostridium difficile infection in the United States.

An epidemic, toxin gene-variant strain of Clostridium difficile.

The epidemiology of community-acquired Clostridium difficile infection: a population-based study

Breakthroughs in the treatment and prevention of Clostridium difficile infection.

Clostridium difficile infections among hospitalized children, United States, 1997-2006.

Fidaxomicin attains high fecal concentrations with minimal plasma concentrations following oral administration in patients with Clostridium difficile infection.

Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays.

P31

scholarly article

P356

10.1093/JPIDS/PIX037

http://www.w3.org/2001/XMLSchema#string

P50

Marian D. Pfefferkorn

P577

2017-05-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28575523

http://www.w3.org/2001/XMLSchema#string

P921

Clostridium difficile

Afọ ọsịsa